Status:
NOT_YET_RECRUITING
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Natera, Inc.
Conditions:
Hereditary Cancer Syndrome
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing ...
Detailed Description
In this prospective trial, a clinician in the department of OBGYN will meet with preconception/pregnant patients who are undergoing obstetrical carrier screening (OCS) at Columbia University affiliate...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age: 18 years - 55 years
- Patients receiving obstetrical-related care at a CUMC-affiliated enrollment site
- Patients who have elected to undergo OCS with the CUMC-affiliated obstetrics provider
- Patients with prior OCS but planned to repeat OCS are eligible
- Patients can speak and read in English or Spanish
- Exclusion criteria:
- Patients who have previously completed a multigene hereditary cancer syndrome panel
- Patients that have a hematologic cancer or hematologic pre-cancer
- Patients who have a history of an autologous bone marrow transplant
Exclusion
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07195071
Start Date
December 1 2025
End Date
December 31 2028
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032